UniProt ID | TAF6L_HUMAN | |
---|---|---|
UniProt AC | Q9Y6J9 | |
Protein Name | TAF6-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 6L | |
Gene Name | TAF6L | |
Organism | Homo sapiens (Human). | |
Sequence Length | 622 | |
Subcellular Localization | Nucleus . | |
Protein Description | Functions as a component of the PCAF complex. The PCAF complex is capable of efficiently acetylating histones in a nucleosomal context. The PCAF complex could be considered as the human version of the yeast SAGA complex.. | |
Protein Sequence | MSEREERRFVEIPRESVRLMAESTGLELSDEVAALLAEDVCYRLREATQNSSQFMKHTKRRKLTVEDFNRALRWSSVEAVCGYGSQEALPMRPAREGELYFPEDREVNLVELALATNIPKGCAETAVRVHVSYLDGKGNLAPQGSVPSAVSSLTDDLLKYYHQVTRAVLGDDPQLMKVALQDLQTNSKIGALLPYFVYVVSGVKSVSHDLEQLHRLLQVARSLFRNPHLCLGPYVRCLVGSVLYCVLEPLAASINPLNDHWTLRDGAALLLSHIFWTHGDLVSGLYQHILLSLQKILADPVRPLCCHYGAVVGLHALGWKAVERVLYPHLSTYWTNLQAVLDDYSVSNAQVKADGHKVYGAILVAVERLLKMKAQAAEPNRGGPGGRGCRRLDDLPWDSLLFQESSSGGGAEPSFGSGLPLPPGGAGPEDPSLSVTLADIYRELYAFFGDSLATRFGTGQPAPTAPRPPGDKKEPAAAPDSVRKMPQLTASAIVSPHGDESPRGSGGGGPASASGPAASESRPLPRVHRARGAPRQQGPGTGTRDVFQKSRFAPRGAPHFRFIIAGRQAGRRCRGRLFQTAFPAPYGPSPASRYVQKLPMIGRTSRPARRWALSDYSLYLPL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
16 | Phosphorylation | FVEIPRESVRLMAES HCCCCHHHHHHHHHH | 17.51 | 28555341 | |
42 | Phosphorylation | LLAEDVCYRLREATQ HHHHHHHHHHHHHHC | 16.72 | - | |
56 | Ubiquitination | QNSSQFMKHTKRRKL CCHHHHHHHHCCCCC | 49.78 | - | |
62 | Ubiquitination | MKHTKRRKLTVEDFN HHHHCCCCCCHHHHH | 53.17 | - | |
85 | Phosphorylation | EAVCGYGSQEALPMR HHHCCCCCCCCCCCC | 19.16 | 17525332 | |
120 | Ubiquitination | ALATNIPKGCAETAV HHHCCCCCCHHHHCE | 63.93 | - | |
137 | Ubiquitination | HVSYLDGKGNLAPQG EEEEECCCCCCCCCC | 44.27 | - | |
145 | Phosphorylation | GNLAPQGSVPSAVSS CCCCCCCCCCHHHHH | 26.13 | 20068231 | |
148 | Phosphorylation | APQGSVPSAVSSLTD CCCCCCCHHHHHCHH | 38.86 | 20068231 | |
151 | Phosphorylation | GSVPSAVSSLTDDLL CCCCHHHHHCHHHHH | 21.24 | 20068231 | |
152 | Phosphorylation | SVPSAVSSLTDDLLK CCCHHHHHCHHHHHH | 28.79 | 20068231 | |
154 | Phosphorylation | PSAVSSLTDDLLKYY CHHHHHCHHHHHHHH | 29.43 | 20068231 | |
177 | Ubiquitination | GDDPQLMKVALQDLQ CCCHHHHHHHHHHHH | 32.71 | 21906983 | |
292 | Phosphorylation | LYQHILLSLQKILAD HHHHHHHHHHHHHCC | 25.88 | 24719451 | |
327 | Phosphorylation | KAVERVLYPHLSTYW HHHHHHHHHHHHHHC | 5.92 | - | |
333 | Phosphorylation | LYPHLSTYWTNLQAV HHHHHHHHCHHHHHH | 13.58 | - | |
335 | Phosphorylation | PHLSTYWTNLQAVLD HHHHHHCHHHHHHHC | 18.68 | - | |
344 | Phosphorylation | LQAVLDDYSVSNAQV HHHHHCCCCCCCEEE | 15.61 | - | |
373 | Ubiquitination | VERLLKMKAQAAEPN HHHHHHHHHHHCCCC | 35.44 | - | |
458 | Phosphorylation | SLATRFGTGQPAPTA HHHHHCCCCCCCCCC | 29.90 | 28634298 | |
464 | Phosphorylation | GTGQPAPTAPRPPGD CCCCCCCCCCCCCCC | 51.94 | 28634298 | |
472 | Acetylation | APRPPGDKKEPAAAP CCCCCCCCCCCCCCC | 66.02 | 26051181 | |
481 | Phosphorylation | EPAAAPDSVRKMPQL CCCCCCCHHHCCCCC | 23.82 | 25159151 | |
489 | Phosphorylation | VRKMPQLTASAIVSP HHCCCCCCEEEEECC | 17.20 | 25850435 | |
491 | Phosphorylation | KMPQLTASAIVSPHG CCCCCCEEEEECCCC | 17.19 | 30266825 | |
495 | Phosphorylation | LTASAIVSPHGDESP CCEEEEECCCCCCCC | 12.69 | 30266825 | |
501 | Phosphorylation | VSPHGDESPRGSGGG ECCCCCCCCCCCCCC | 25.33 | 30266825 | |
505 | Phosphorylation | GDESPRGSGGGGPAS CCCCCCCCCCCCCCC | 35.23 | 22496350 | |
512 | Phosphorylation | SGGGGPASASGPAAS CCCCCCCCCCCCCCC | 26.54 | 26074081 | |
514 | Phosphorylation | GGGPASASGPAASES CCCCCCCCCCCCCCC | 42.70 | 26074081 | |
519 | Phosphorylation | SASGPAASESRPLPR CCCCCCCCCCCCCCC | 37.91 | 26074081 | |
521 | Phosphorylation | SGPAASESRPLPRVH CCCCCCCCCCCCCHH | 36.38 | 26074081 | |
541 | Phosphorylation | PRQQGPGTGTRDVFQ CCCCCCCCCCHHHHH | 38.21 | 28555341 | |
549 | Ubiquitination | GTRDVFQKSRFAPRG CCHHHHHHHCCCCCC | 31.94 | - | |
555 | Methylation | QKSRFAPRGAPHFRF HHHCCCCCCCCCEEE | 50.94 | 24129315 | |
555 | Asymmetric dimethylarginine | QKSRFAPRGAPHFRF HHHCCCCCCCCCEEE | 50.94 | - | |
561 | Asymmetric dimethylarginine | PRGAPHFRFIIAGRQ CCCCCCEEEEEECCC | 20.86 | - | |
561 | Methylation | PRGAPHFRFIIAGRQ CCCCCCEEEEEECCC | 20.86 | 24129315 | |
567 | Methylation | FRFIIAGRQAGRRCR EEEEEECCCCHHCCC | 17.72 | 54559813 | |
567 | Dimethylation | FRFIIAGRQAGRRCR EEEEEECCCCHHCCC | 17.72 | - | |
586 | Phosphorylation | QTAFPAPYGPSPASR CCCCCCCCCCCHHHH | 43.72 | 29396449 | |
589 | Phosphorylation | FPAPYGPSPASRYVQ CCCCCCCCHHHHHHH | 28.83 | 21815630 | |
592 | Phosphorylation | PYGPSPASRYVQKLP CCCCCHHHHHHHCCC | 27.77 | 29396449 | |
593 | Methylation | YGPSPASRYVQKLPM CCCCHHHHHHHCCCC | 37.43 | 24129315 | |
593 | Asymmetric dimethylarginine | YGPSPASRYVQKLPM CCCCHHHHHHHCCCC | 37.43 | - | |
594 | Phosphorylation | GPSPASRYVQKLPMI CCCHHHHHHHCCCCC | 12.53 | 22210691 | |
597 | Ubiquitination | PASRYVQKLPMIGRT HHHHHHHCCCCCCCC | 44.51 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TAF6L_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TAF6L_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TAF6L_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
TAF9B_HUMAN | TAF9B | physical | 25416956 | |
ATX7_HUMAN | ATXN7 | physical | 28514442 | |
ST65G_HUMAN | SUPT7L | physical | 28514442 | |
KAT2B_HUMAN | KAT2B | physical | 28514442 | |
SUPT3_HUMAN | SUPT3H | physical | 28514442 | |
TAF9B_HUMAN | TAF9B | physical | 28514442 | |
TAF12_HUMAN | TAF12 | physical | 28514442 | |
SP20H_HUMAN | SUPT20H | physical | 28514442 | |
KAT2A_HUMAN | KAT2A | physical | 28514442 | |
TAF9_HUMAN | TAF9 | physical | 28514442 | |
TAF10_HUMAN | TAF10 | physical | 28514442 | |
TRRAP_HUMAN | TRRAP | physical | 28514442 | |
STIP1_HUMAN | STIP1 | physical | 28514442 | |
HSP7C_HUMAN | HSPA8 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-85, AND MASSSPECTROMETRY. |